SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-061245
Filing Date
2022-10-03
Accepted
2022-10-03 16:05:24
Documents
2
Period of Report
2022-10-03

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea166652-6k_biondvaxpharma.htm 6-K 18964
2 PRESS RELEASE, DATED SEPTEMBER 30, 2022 ea166652ex99-1_biondvax.htm EX-99.1 13957
  Complete submission text file 0001213900-22-061245.txt   34016
Mailing Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000
Business Address JERUSALEM BIOPARK, 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 972-8-9302529
BiondVax Pharmaceuticals Ltd. (Filer) CIK: 0001611747 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37353 | Film No.: 221287509
SIC: 2836 Biological Products, (No Diagnostic Substances)